Sinocro

Sinocro is a full-service Contract Research Organization (CRO) headquartered in Beijing, China, providing clinical development and regulatory services to the global pharmaceutical and biotechnology sectors. Founded in 2004, the company specializes in navigating the complex regulatory environment of the National Medical Products Administration (NMPA) to facilitate clinical trials for both domestic and international clients. Sinocro's service portfolio includes Phase I-IV clinical trial management, site monitoring, data management, biostatistics, and medical writing. The firm maintains a strong presence in therapeutic areas such as oncology, cardiovascular disease, and infectious diseases, leveraging its local expertise to accelerate drug development timelines in the Asia-Pacific region. By offering end-to-end support from regulatory submission to final clinical study reports, Sinocro acts as a critical partner for companies seeking to access the Chinese healthcare market.